Ezio Ghigo
Founder at Millendo Therapeutics SAS
Profile
Ezio Ghigo is the founder of Millendo Therapeutics SAS, which was founded in 2007.
He held the title of Co-Chief Scientific Officer from 2007 to 2010.
Currently, Dr. Ghigo is the Chairman at the University of Turin.
In the past, he worked as a Consultant at UCB Pharma GmbH, Theratechnologies, Inc., Novartis AG, Pharmacia AB, Europeptides GEIE, Pierrel SpA, Kabivitrum AB, Pfizer NV, and Ipsen NV.
Ezio Ghigo active positions
| Companies | Position | Start |
|---|---|---|
Millendo Therapeutics SAS
 Millendo Therapeutics SAS Medical SpecialtiesHealth Technology Millendo Therapeutics SAS provides pharmaceutical research services. It engages in the development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases and rare diseases. The company was founded by Thierry Abribat, André de Villers, Ezio Ghigo and Aart Jan van der Lely on April 23, 2007 and is headquartered in Ecully, France. | Founder | 08/09/2009 |
| University of Turin | Chairman | 08/09/2009 |
Former positions of Ezio Ghigo
| Companies | Position | End |
|---|---|---|
| Pfizer NV/SA | Corporate Officer/Principal | - |
Ipsen NV
 Ipsen NV Pharmaceuticals: MajorHealth Technology Part of Ipsen SA, Ipsen NV is a Belgian biopharmaceutical company that improves patients' lives through research and innovation in oncology, rare disease, and neuroscience. Founded in 1982, the company is based in Merelbeke, Belgium. Ipsen is a global mid-sized biopharmaceutical company that focuses on improving patients' lives through its research and innovation in the field of oncology, rare diseases, and neuroscience. | Corporate Officer/Principal | - |
| NOVARTIS AG | Corporate Officer/Principal | - |
| THERATECHNOLOGIES INC. | Corporate Officer/Principal | - |
UCB Pharma GmbH
 UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| PIERREL S.P.A. | Health Technology |
| NOVARTIS AG | Health Technology |
| THERATECHNOLOGIES INC. | Health Technology |
| Private companies | 7 |
|---|---|
Millendo Therapeutics SAS
Millendo Therapeutics SAS Medical SpecialtiesHealth Technology Millendo Therapeutics SAS provides pharmaceutical research services. It engages in the development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases and rare diseases. The company was founded by Thierry Abribat, André de Villers, Ezio Ghigo and Aart Jan van der Lely on April 23, 2007 and is headquartered in Ecully, France. | Health Technology |
| Kabivitrum AB | |
| Pharmacia AB | Health Technology |
Europeptides GEIE
 Europeptides GEIE Miscellaneous Commercial ServicesCommercial Services Europeptides GEIE is a French pharmaceutical company that specializes in researching and developing products for the reproductive health care sector. The company is based in Argenteuil, France. Europeptides GEIE was acquired by Ardana Plc from E.ON SE on July 11, 2002 for $27.87 million. | Commercial Services |
UCB Pharma GmbH
UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany. | Health Technology |
| Pfizer NV/SA | |
Ipsen NV
Ipsen NV Pharmaceuticals: MajorHealth Technology Part of Ipsen SA, Ipsen NV is a Belgian biopharmaceutical company that improves patients' lives through research and innovation in oncology, rare disease, and neuroscience. Founded in 1982, the company is based in Merelbeke, Belgium. Ipsen is a global mid-sized biopharmaceutical company that focuses on improving patients' lives through its research and innovation in the field of oncology, rare diseases, and neuroscience. | Health Technology |
- Stock Market
- Insiders
- Ezio Ghigo
